Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H L Messmore

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
Clinics in Laboratory Medicine|March 1, 1995
Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disordersJ Fareed, R L Bick, D A Hoppensteadt, et al.
The International Journal of Artificial Organs|November 1, 1987
Heparin-associated thrombocytopenia in maintenance hemodialysis patientsD J Leehey, R J Kanak, H L Messmore, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptidesG Claeson, J Fareed, C Larsson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass modelJ M Walenga, M Bakhos, H L Messmore, et al.
Radiology|February 1, 1990
Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast mediaM H Hwang, Z E Piao, D K Murdock, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Soluble adhesion molecules in the HIT syndrome: pathophysiologic role and therapeutic modulationJ Fareed, J M Walenga, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|June 5, 1999
Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulationJ Fareed, J M Walenga, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodiesS Ahmad, W P Jeske, J M Walenga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Circadian interrelationships among levels of plasma fibrinogen, blood platelets, and serum interleukin-6E L Kanabrocki, R B Sothern, H L Messmore, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 8, 2001
Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectinE L Kanabrocki, M George, R C Hermida, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Clinics in Laboratory Medicine|March 1, 1995
Molecular markers of hemostatic activation. Implications in the diagnosis of thrombosis, vascular, and cardiovascular disordersJ Fareed, R L Bick, D A Hoppensteadt, et al.
The International Journal of Artificial Organs|November 1, 1987
Heparin-associated thrombocytopenia in maintenance hemodialysis patientsD J Leehey, R J Kanak, H L Messmore, et al.
Advances in Experimental Medicine and Biology|January 1, 1979
Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptidesG Claeson, J Fareed, C Larsson, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 1, 1991
Comparison of recombinant hirudin and heparin as an anticoagulant in a cardiopulmonary bypass modelJ M Walenga, M Bakhos, H L Messmore, et al.
Radiology|February 1, 1990
Risk of thromboembolism during diagnostic and interventional cardiac procedures with nonionic contrast mediaM H Hwang, Z E Piao, D K Murdock, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Soluble adhesion molecules in the HIT syndrome: pathophysiologic role and therapeutic modulationJ Fareed, J M Walenga, D A Hoppensteadt, et al.
Seminars in Thrombosis and Hemostasis|June 5, 1999
Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulationJ Fareed, J M Walenga, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Synthetic pentasaccharides do not cause platelet activation by antiheparin-platelet factor 4 antibodiesS Ahmad, W P Jeske, J M Walenga, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Circadian interrelationships among levels of plasma fibrinogen, blood platelets, and serum interleukin-6E L Kanabrocki, R B Sothern, H L Messmore, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|November 8, 2001
Day-night variations in blood levels of nitric oxide, T-TFPI, and E-selectinE L Kanabrocki, M George, R C Hermida, et al.
Pageof 7